UBS raised the firm’s price target on Life360 (LIF) to $85 from $71 and keeps a Buy rating on the shares. A healthy U.S. ecosystem underpinned positive earnings revisions, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIF:
- Life360 price target raised to $92 from $87 at Stifel
- Life360’s Strong Financial Performance and Growth Prospects Justify Buy Rating
- Life360 price target raised to $95 from $62 at Citizens JMP
- Life360 Reports Strong Q2 2025 Results and Leadership Change
- Closing Bell Movers: Green Dot up 20% after Q2 beat and raise